<DOC>
	<DOCNO>NCT00382447</DOCNO>
	<brief_summary>Comparison researcher ' standard nebulizer breath actuate nebulizer examine breathe medication deliver quickly effectively effectively standard nebulizer .</brief_summary>
	<brief_title>Breath Actuated Nebulizer Study Protocol</brief_title>
	<detailed_description>Background : Generic nebulizer well breath actuated nebulizer available FDA approve administer therapy year . Recently interest use breath actuate nebulizer stream-line patient care hospital setting . Literature find breath actuated nebulizer faster deliver equivalent dose , effective measure patient response therapy . There standard method convert generic nebulizer breath actuate technology . Objectives : We want evaluate use Breath Actuated Nebulizer ( BAN ) technology versus generic nebulizer improve quality patient treatment reduce nebulization duration allow staff time complete patient assessment . Inclusion Criteria : - Adult patient order routine 2.5 mg albuterol sulfate nebulizer therapy order either Q4 Q6 hour consent study . Exclusion Criteria : - Adults nebulizer therapy order frequently Q4 hour . - Adults nebulizer therapy order less frequently Q6 hour . - Pregnant patient exclude . - Adults order albuterol sulfate &gt; 2.5 mg. - Adults intensive care unit ( ICU ) Emergency Department . Protocol : 1 . Adult patient order Q4 Q6 2.5 mg albuterol sulfate nebulizer therapy without anticholinergic agent ( ipratropium/tiotropium ) 2 . Patient consent 3 . Patient randomize receive either `` Control Method '' `` Study Method '' first ( see method ) 4 . The 1st morning consent , first study method use 5 . The 2nd morning consent , study method use 6 . Study second study method complete Control Method : 1 . Baseline patient data spirometry record include : Forced Vital Capacity ( FVC ) , Forced Expiratory Volume one second ( FEV1 ) , Forced Expiratory Ratio ( FER ) , Peak Expiratory Flow ( PEF ) , HR , Resting RR , Breath sound , Pulse Oximetry ( SpO2 ) . 2 . 2.5 mg albuterol sulfate give generic nebulizer 0700 treatment time . Anticholinergic agent ipratropium tiotropium give order . 3 . Follow-up patient data spirometry record 15 minute 2 hour follow treatment . 4 . Subsequent treatment day give standard . Study Method : 1 . Baseline patient data spirometry record include : Forced Vital Capacity ( FVC ) , Forced Expiratory Volume one second ( FEV1 ) , Forced Expiratory Ratio ( FER ) , Peak Expiratory Flow ( PEF ) , Heart rate ( HR ) , Resting respiratory rate ( RR ) , Breath sound , Pulse Oximetry ( SpO2 ) . 2 . Albuterol sulfate ( 2.5 mg ) give via Aero Eclipse BAN 0.5 ml saline 0.5 ml ipratropium bromide ( ipratropium bromide order ) . 3 . Follow-up patient data spirometry record 15 minute 2 hour follow treatment . 4 . Subsequent treatment day give order .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>Adult patient order routine 2.5 mg albuterol sulfate nebulizer therapy order either Q4 Q6 hour consent study . Adults nebulizer therapy order frequently Q4 hour . Adults nebulizer therapy order less frequently Q6 hour . Pregnant patient exclude . Adults order albuterol sulfate &gt; 2.5 mg . Adults ICU Emergency Department .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>breath actuate nebulizer</keyword>
	<keyword>nebulizer</keyword>
</DOC>